Thus, an evaluation of drug resistance in tumor cells of leukemia patients measured as MDR1 mRNA levels has prognostic value for individual hematological disorders, in particular for newly diagnosed patients with AML. The gene discussed is ABCB1; the disease is acute myeloid leukemia.